1. Home
  2. SUNB vs BNTX Comparison

SUNB vs BNTX Comparison

Compare SUNB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SUNB

Sunbelt Rentals Holdings Inc. Common Stock

N/A

Current Price

$72.76

Market Cap

31.8B

ML Signal

N/A

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$100.91

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNB
BNTX
Founded
1947
2008
Country
United States
Germany
Employees
8402
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.8B
24.2B
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
SUNB
BNTX
Price
$72.76
$100.91
Analyst Decision
Hold
Strong Buy
Analyst Count
5
13
Target Price
$70.75
$133.46
AVG Volume (30 Days)
2.1M
800.8K
Earning Date
06-16-2026
05-05-2026
Dividend Yield
1.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.31
N/A
Revenue Next Year
$5.06
$3.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$61.03
$79.81
52 Week High
$78.05
$124.00

Technical Indicators

Market Signals
Indicator
SUNB
BNTX
Relative Strength Index (RSI) 52.01 52.71
Support Level $61.77 $99.08
Resistance Level N/A $113.05
Average True Range (ATR) 2.71 3.66
MACD 0.80 0.24
Stochastic Oscillator 56.75 41.11

Price Performance

Historical Comparison
SUNB
BNTX

About SUNB Sunbelt Rentals Holdings Inc. Common Stock

Sunbelt Rentals (formerly UK-based Ashtead Group) is the number two equipment rental company in the US (11% market share), with a smaller presence in Canada and the UK. Sunbelt operates a rental fleet of just over $15 billion across a network of 1,200 stores in the US, nearly CAD 2 billion of fleet and 135 stores in Canada, and GBP 1.1 billion and 190 stores in the UK. The company has experienced rapid growth over the past decade as its customers increasingly turn to rental versus owning equipment outright. The general tool business has been augmented by the Specialty Rental business, which has grown to 30% of the mix. Revenue is now greater than 50% nonconstruction, with the remainder focused more directly on commercial construction.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: